Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 1826 - 1850 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▼
Diacylglycerophosphoinositolglycans LMGP15010240
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:2(9Z,12Z)/18:0)
126457608 1686.836908 C76H135O38P
Gangliosides LMSP0601AK07
  • GD3(d18:1/24:1(15Z))
  • NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262050 1553.918132 C76H135N3O29
Gangliosides LMSP0601AN01
  • GD2(d18:1/16:0)
  • GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262068 1646.887956 C76H134N4O34
Diacylglycerophosphoinositolglycans LMGP15010241
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:2(9Z,12Z)/18:1(9Z))
126457609 1684.821258 C76H133O38P
LMSL03001295
  • 2-O-octadecanoyl,3-O-(2S,4S,6S,8R,10R,12R,14R,16R,18R-nonamethyl)-19-hydroxy-hexatriacontanoyl)-2'-sulfotrehalose
  • AC2SGL(18:0/36:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[S],12Me[R],14Me[R],16Me[R],18Me[R],19OH))
126457736 1349.012427 C75H144O17S
Diacylglycerophosphoinositolglycans LMGP15010210
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1,2-dioctadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(18:0/18:0)
126457578 1676.852558 C75H137O38P
Gangliosides LMSP0601CI06
  • GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
52931294 1511.943952 C75H137N3O27
Gangliosides LMSP0601AM06
  • GM2(d18:1/26:0)
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262065 1495.949037 C75H137N3O26
Gangliosides LMSP0601EK06
  • NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262833 1495.949037 C75H137N3O26
Gangliosides LMSP0601DD04
  • KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262583 1560.912713 C75H136N2O31
Gangliosides LMSP0601DF04
  • Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • KDN-GM1(d18:1/22:0)
44262599 1560.912713 C75H136N2O31
Gangliosides LMSP0601EB04
  • KDN-lactotetraosylceramide(d18:1/22:0)
  • KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262759 1560.912713 C75H136N2O31
Gangliosides LMSP0601EC04
  • KDN(2-6)lactotetraosylceramide(d18:1/22:0)
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262767 1560.912713 C75H136N2O31
Gangliosides LMSP0601GE04
  • KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44263167 1560.912713 C75H136N2O31
Gangliosides LMSP0601GG04
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/22:0)
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44263183 1560.912713 C75H136N2O31
Diacylglycerophosphoinositolglycans LMGP15010242
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM6(16:0/14:0)
126457610 1754.811483 C75H135O43P
Diacylglycerophosphoinositolglycans LMGP15010211
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(18:0/18:1(9Z))
126457579 1674.836908 C75H135O38P
Diacylglycerophosphoinositolglycans LMGP15010216
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(18:1(9Z)/18:0)
126457584 1674.836908 C75H135O38P
Gangliosides LMSP0601BY03
  • NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262366 1589.902877 C75H135N3O32
Gangliosides LMSP0601CJ03
  • Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262438 1589.902877 C75H135N3O32
Gangliosides LMSP0601FF03
  • NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262982 1589.902877 C75H135N3O32
Gangliosides LMSP0601AH03
  • NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262022 1573.907962 C75H135N3O31
Gangliosides LMSP0601AP03
  • GM1(d18:1/20:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262086 1573.907962 C75H135N3O31
Gangliosides LMSP0601AY03
  • GM1b(d18:1/20:0)
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262158 1573.907962 C75H135N3O31
Gangliosides LMSP0601BM03
  • GM1alpha(d18:1/20:0)
  • Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44262270 1573.907962 C75H135N3O31

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024